(Q40673826)

English

Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7.

scientific article published on March 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7. (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Semliki Forest virus

0 references

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

1

object named as

Toos Daemen

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

6

object named as

Jan Wilschut

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

author name string

Annelies Riezebos-Brilman

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Laura Bungener

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Joke Regts

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Bert Dontje

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

language of work or name

0 references

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

11-12

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1082-1088

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Cancer burden in the year 2000. The global picture

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistent human papillomavirus infection and cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Revealing the potential of DNA-based vaccination: lessons learned from the hepatitis B virus surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant viruses as a tool for therapeutic vaccination against human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The short arm of chromosome 11 likely is involved in the regulation of the human papillomavirus type 16 early enhancer-promoter and in the suppression of the transforming activity of the viral DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Dendritic Cells as Carriers for a Cytotoxic T-Lymphocyte Epitope-Based Peptide Vaccine in Protection Against a Human Papillomavirus Type 16-Induced Tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral recombinant vaccines to the E6 and E7 antigens of HPV-16

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors im

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction and characterization of recombinant VLPs and Semliki-Forest virus live vectors for comparative evaluation in the SHIV monkey model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The Semliki Forest virus vector induces p53-independent apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Building better vaccines: how apoptotic cell death can induce inflammation and activate innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900558-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(02)00558-3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40673826&oldid=1817192641"